Tenaya Therapeutics (TNYA) Other Non-Current Assets (2020 - 2026)

Tenaya Therapeutics' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $3.8 million for Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 21.36% year-over-year to $3.8 million in Q1 2026; TTM through Mar 2026 was $3.8 million, a 21.36% decrease from a year earlier, with the FY2025 full-year figure at $4.2 million, down 11.85% from the prior year.
• Other Non-Current Assets slipped to $3.8 million in Q1 2026 per TNYA's latest filing, from $4.2 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $5.7 million in Q3 2023 and bottomed at $399000.0 in Q1 2022.
• The 5-year median for Other Non-Current Assets is $4.8 million (2022), against an average of $4.5 million.
• Across the five-year window, Other Non-Current Assets fell 27.06% in 2022 and jumped 1060.4% in 2023, its largest moves.
• Year by year, Other Non-Current Assets stood at $4.8 million in 2022, then climbed by 18.44% to $5.7 million in 2023, then retreated by 15.15% to $4.8 million in 2024, then fell by 11.85% to $4.2 million in 2025, then decreased by 10.86% to $3.8 million in 2026.
• Per Business Quant, the three latest TNYA Other Non-Current Assets figures stand at $3.8 million (Q1 2026), $4.2 million (Q4 2025), and $4.2 million (Q3 2025).